# Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery

> **NCT00832273** · — · NO_LONGER_AVAILABLE · sponsor: **Vital Therapies, Inc.**

## Conditions studied

- Liver Failure

## Interventions

- **DEVICE:** ELAD®

## Key facts

- **NCT ID:** NCT00832273
- **Lead sponsor:** Vital Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832273, "Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00832273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*